Cryopets
Cryopets is a U.S. pet cryopreservation service that uses vitrification and custom cryo ambulances to preserve companion animals at end of life, serving pet owners across the continental United States through a waitlist-based direct-to-consumer membership model.
- Company typePrivate
- Founded2022
- HeadquartersBoerne, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Cryopets does
Cryopets, Inc. is a privately held, U.S.-based (Boerne/San Antonio, Texas) pet cryopreservation service founded in 2022 by Thiel Fellow Kai Micah Mills. The company applies human-cryopreservation techniques — vitrification with VM-1 and M22 cryoprotective agents, slow liquid-nitrogen cooldown to −196°C, and long-term storage in power-independent cryogenic dewars — to companion animals at the end of their natural lives. Its field-deployable cryo ambulances perform stabilization, cryoprotection, and transport anywhere in the continental US, and the company is constructing a permanent long-term care facility in Boerne alongside a planned American Biostasis Foundation nonprofit, co-built with Tomorrow Bio, CryoDAO, and HydraDAO.
The product offering is structured as three tiered cryopreservation protocols — Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze — augmented by the Ambulance SST (Standby, Stabilization, Transport) field service. Pricing is not yet public and is described as "coming soon," with payments permitted over time until preservation. Customer acquisition is direct-to-consumer via a free website waitlist (capped at 10,000 free spots), supplemented by phone consultation and emergency response lines. The scientific team is led by CSO Chana Phaedra (formerly of Alcor, the Institute for Evidence Based Cryonics, and Advanced Neural Biosciences), with founder-led linkages to CryoDAO and HydraDAO providing research capital and ecosystem alignment.
Revenue is undisclosed and the company has just completed its first commercial preservation (a Siberian Husky named Datsyuk). Backed by approximately $1.5M raised in December 2025 (Prelude, Valyrian, Zee Prime Capital) alongside earlier support from Thiel Fellowship, Gaingels, Novelty Ventures, TruVenturo, Roadrunner Ventures, and others, Cryopets is in a pre-commercial scaling phase: building clinical capacity, formalizing pricing, and constructing the long-term care infrastructure required to deliver on a multi-decade custodianship promise to pet owners.
Cryopets firmographics
Firmographics- Name
- Cryopets
- Legal name
- Cryopets, Inc.
- Website
- https://cryopets.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Cryopets is a U.S. pet cryopreservation service that uses vitrification and custom cryo ambulances to preserve companion animals at end of life, serving pet owners across the continental United States through a waitlist-based direct-to-consumer membership model.
- Ownership category
- akta.pro rank
Cryopets industry classification
Industry- Product category
- Pet Cryopreservation Services
- akta.pro primary industry
- Reproductive & Endocrinology Diagnostics (Fertility, Hormones) (HLAMADAF)
- akta.pro secondary industry
- Hot/Cold Therapy Services (Cryotherapy/Ice Baths) (HSALAFAH)
Keywords
Where Cryopets is headquartered
LocationHeadquarters
- HQ city
- Boerne
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Cryopets business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Infrastructure, Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Revenue model
- Cryosleep Procedure Services: Cryopets generates revenue through cryosleep procedure services with three tiers: Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze. Pricing can be paid over time up until the preservation. Membership includes access to the cryosleep procedure and long-term care.
- Long-term Storage: One-time storage payment for indefinite cryogenic preservation. Families pay for storage one time, not as ongoing monthly or annual bill. This one-time storage fund is managed conservatively to stay ahead of inflation over time.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Standard Preservation using VM-1 cryoprotectant |
| Other | Pay-as-you-go | Advanced Preservation using M22 cryoprotectant |
| Other | Pay-as-you-go | Straight Freeze (traditional freezing without cryoprotectants) |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Cryopets product offering
Product offeringCore offering
Cryopets provides pet cryopreservation (cryosleep) services through three procedure tiers — Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze — combined with mobile cryo ambulance standby, stabilization, and transport, slow liquid nitrogen cooldown, and indefinite cryogenic dewar storage at -196°C. The service is delivered directly to pet owners, with procedures performed in the field by trained surgeons near the pet's veterinary clinic.
Product overview
Cryopets offers a tiered cryopreservation service for pets, comprising three procedure options—Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze—alongside an Ambulance SST (Standby, Stabilization and Transport) service. The service portfolio follows a five-stage process: stabilization using cryo ambulances, transport to the facility, slow cooldown in specialized chambers, long-term cryosleep storage in liquid nitrogen dewars, and future revival when medical technology permits. The higher-tier protocols differ in cryoprotectant quality, inclusion of CT scan assessment, and ambulance coverage.
Differentiator
Problem solved
Functional benefit
Products and services
- Standard Preservation (VM-1) Cryopets' standard cryopreservation protocol using VM-1 cryoprotectant for pet owners, balancing quality and cost. Includes slow cooldown, long-term liquid nitrogen storage, CT scan for quality assessment, and Ambulance SST. Designed for most families seeking a balance of quality and value.
- Advanced Preservation (M22) Cryopets' most advanced cryopreservation protocol using the research-grade M22 cryoprotectant, which has enabled whole mammalian organ recovery. Includes slow cooldown, liquid nitrogen storage, CT scan quality assessment, and Ambulance SST. Intended for pet owners who want the best possible preservation quality.
- Straight Freeze Traditional freezing preservation without cryoprotectants, used when other options are not possible. Lower-cost option with greater risk of cellular damage from ice formation. Includes slow cooldown and long-term liquid nitrogen storage but does not include cryoprotective agents, CT scan quality assessment, or Ambulance SST.
- Ambulance SST (Standby, Stabilization and Transport) Field cryopreservation service where Cryopets drives custom-built cryo ambulances to pet owners anywhere in the continental U.S., performs the full cryoprotection procedure near the pet's veterinary clinic, and transports the pet to the long-term care facility. Time-critical service for optimal preservation from the first moment.
Companies that use Cryopets
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
Cryopets technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Cryopets partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- American Biostasis Foundation (ABF)coreABF is the upcoming nonprofit and planned home of Cryopets' permanent long-term patient care facility. It is purpose-built to operate secure, indefinite patient storage alongside cryopreservation research and public education. ABF is being built in partnership with Cryopets, Tomorrow Bio, CryoDAO, and HydraDAO to align clinical providers, research capital, and governance for responsible scaling.
- Tomorrow BiocoreLeading biostasis provider partnering with Cryopets to build the American Biostasis Foundation. Tomorrow Bio is part of the coalition supporting ABF's nonprofit model for transparent custodianship for people and pets in cryostorage.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
Cryopets competitors and assessment
Company assessmentDirect peers
- Tomorrow Bio: Berlin-based human cryopreservation provider operating field standby/transport across Europe. Directly comparable business model (ambulance SST, vitrification, long-term storage), with Cryopets explicitly partnering with Tomorrow Bio via the American Biostasis Foundation coalition.
Broad incumbents
- Alcor Life Extension Foundation: Long-established (1972) human cryopreservation organization with full-body and neurocryopreservation services. Comparable vitrification protocols (M22 is associated with Alcor-adjacent research) and Cryopets' CSO is a former Alcor researcher, making Alcor the most direct scientific lineage peer.
- Cryonics Institute: Michigan-based human cryopreservation nonprofit operating since 1976. Comparable long-term liquid nitrogen storage model and member-funded custody structure, though without the field-deployment ambulance model that differentiates Cryopets.
- Oregon Cryonics: Standby, stabilization, and transport provider for human cryopreservation cases across the western US. Directly comparable field-deployment logistics role to Cryopets' ambulance SST, but as a B2B service provider rather than a consumer-facing brand.
- Yinfeng Cryobiology: China-based cryobiology company offering cryopreservation services (notably including what they describe as the first human cryopreservation in China). Comparable full-stack cryopreservation model with state-affiliated research backing, addressing a different geographic and regulatory environment.
Emerging players
- Acorn Biolabs: Pet stem cell banking company enabling owners to preserve their pet's living cells for future regenerative use. Closest commercial analog to Cryopets' value proposition (preserving pet biology for future medical use), though focused on cellular rather than whole-body preservation.
- Gallant (formerly Forever Labs): Veterinary regenerative medicine company offering pet stem cell banking and regenerative therapies. Addresses the same 'preserve pet biology for future treatment' pain point as Cryopets, with a more validated near-term delivery model but no whole-body preservation.
Regional players
- Southern Cryonics: Australia's first cryopreservation organization, offering full-body and neurocryopreservation services. Operates the same full-stack cryopreservation + long-term storage model as Cryopets but in a different geographic market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Cryopets social profiles
Digital presenceCryopets financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cryopets leadership team
Management profileNumber of profiles
Profiles6 records
Cryopets funding detail
Funding detailFunding overview
Funding rounds1 record
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cryopets M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cryopets
What does Cryopets do?
Cryopets provides pet cryopreservation (cryosleep) services through three procedure tiers — Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze — combined with mobile cryo ambulance standby, stabilization, and transport, slow liquid nitrogen cooldown, and indefinite cryogenic dewar storage at -196°C. The service is delivered directly to pet owners, with procedures performed in the field by trained surgeons near the pet's veterinary clinic.
Is Cryopets a public or private company?
Cryopets is a private company. It is classified as venture growth investor backed and is currently operating.
When was Cryopets founded?
Cryopets was founded in 2022. It employs 1 to 10 people.
Where is Cryopets based?
Cryopets is headquartered in Boerne, United States, in the North America region.
How does Cryopets make money?
Two revenue lines are on record. Cryosleep Procedure Services are the primary driver. The others are long-term Storage.
Who are Cryopets's main competitors?
Tomorrow Bio is listed as a direct peer. Broad incumbents are Alcor Life Extension Foundation, Cryonics Institute, Oregon Cryonics and Yinfeng Cryobiology. Emerging players are Acorn Biolabs and Gallant (formerly Forever Labs). Southern Cryonics is listed as a regional player.
Does Cryopets have an API?
No public API is recorded for Cryopets.
What industry is Cryopets in?
Cryopets's product category is Pet Cryopreservation Services. Its primary akta.pro industry code is HLAMADAF, Reproductive & Endocrinology Diagnostics (Fertility, Hormones), with a secondary code of HSALAFAH, Hot/Cold Therapy Services (Cryotherapy/Ice Baths).